SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced a poster presentation titled “Highly Scalable Barcoded Magnetic Beads for Multiplexed Assays”, subtitled “Digital Multiplexing System offers testing solutions for molecular diagnostics, biomarkers validation and companion diagnostics with high throughput, accuracy, and affordability” at the 42nd Annual Oak Ridge Conference on April 22-23 in San Jose, California. The poster was presented by Dr. Gao Chen, Sr. Research Scientist at Applied BioCode.
Applied BioCode’s Barcoded Magnetic Beads digital multiplexing technology, along with the BioCode-1000 Analyzer for barcode and fluorescence detection, results in an extremely flexible digital multiplexing platform suited for a wide variety of biological applications, such as clinical diagnostics, molecular diagnostics, gene mutation analysis, companion diagnostics, drug resistance genotyping, pharmaceutical drug discovery and biomarkers validation.
The Poster Presentation focuses on the results from a 10-plex Cytokine Immunoassay panel and an 8-plex panel for Thrombo SNP Genotyping targets.
The BioCode-1000 Analyzer is a rapid, simple, and robust Barcoded Magnetic Beads digital multiplexing system for a 96-well microplate format. The system is used to detect from 2 to 128-plex Nucleic Acid or Protein targets in individual microwells. The digital multiplexing system can scan a 96-well microplate, decode barcodes, measure label fluorescence, and display results in only 40 seconds per microwell. The system is extremely sensitive (0.5 fm/ml GAPDH (DNA) and 1.0 pg/ml IL-2 (protein) with PE label) and has been used for a variety of panel tests in molecular diagnostics, companion diagnostics, and biomarkers validation. The Biocode-1000 Analyzer simplifies the testing of multiplex assays while offering high throughput, high accuracy, and affordability.
About Applied BioCode:
Applied BioCode, Inc. is a privately held biotechnology company with headquarters located in Santa Fe Springs, California. Applied BioCode develops, manufactures, and markets highly multiplexed products for the Clinical Diagnostics, Bioresearch, and Clinical Trials markets. Applied BioCode maintains an extensive collaborative network with universities, government laboratories, and industrial partners. This approach enables them to optimize efficiency and resources and leverage those to help its customers maximize the benefit of its powerful tools and collaborative networks.